|
| 神州细胞-U(688520)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-05-10 | 206.91 | 0.46% | 44533.57 | 0.00 | 9142.82 | 20.53% | 定向增发机构配售股份 | | 2024-01-02 | 34390.76 | 77.22% | 44326.66 | 206.91 | 9142.82 | 20.53% | 首发原股东限售股份 | | 2023-05-10 | 793.09 | 1.78% | 9935.90 | 34597.67 | 9142.82 | 20.53% | 定向增发机构配售股份 | | 2022-06-22 | 200.00 | 0.46% | 9142.82 | 34390.76 | 9142.82 | 21.00% | 首发战略配售股份 | | 2022-03-28 | 2033.57 | 4.67% | 8942.82 | 34590.76 | 8942.82 | 20.54% | 首发原股东限售股份 |
|